These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 27031604)

  • 41. Brazilian guidelines for biorepositories and biobanks of human biological material.
    Marodin G; Salgueiro JB; Motta Mda L; Santos LM
    Rev Assoc Med Bras (1992); 2013; 59(1):72-7. PubMed ID: 23440145
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Validation of alternative methods for toxicity testing.
    Bruner LH; Carr GJ; Curren RD; Chamberlain M
    Environ Health Perspect; 1998 Apr; 106 Suppl 2(Suppl 2):477-84. PubMed ID: 9599695
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The Brazilian National Health Surveillance Agency performance evaluation at the management contract model].
    Moreira EM; Costa EA
    Cien Saude Colet; 2010 Nov; 15 Suppl 3():3381-91. PubMed ID: 21120326
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Refining animal experiments: the first Brazilian regulation on animal experimentation.
    de A e Tréz T
    Altern Lab Anim; 2010 Jun; 38(3):239-44. PubMed ID: 20602540
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Quality of medicines: Deficiencies found by Brazilian Health Regulatory Agency (ANVISA) on good manufacturing practices international inspections.
    Geyer ARC; Sousa VD; Silveira D
    PLoS One; 2018; 13(8):e0202084. PubMed ID: 30089162
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The contributions of the European cosmetics industry to the development of alternatives to animal testing: dialogue with ECVAM and future challenges.
    de Silva O;
    Altern Lab Anim; 2002 Dec; 30 Suppl 2():189-93. PubMed ID: 12513672
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Validation and regulatory acceptance of new carcinogenicity tests.
    Spielmann H
    Toxicol Pathol; 2003; 31(1):54-9. PubMed ID: 12597449
    [TBL] [Abstract][Full Text] [Related]  

  • 48. FRAME Annual Lecture. International co-operation: an essential requirement for replacing animal toxicity tests.
    Spielmann H
    Altern Lab Anim; 2001; 29(6):637-46; discussion 647-8. PubMed ID: 11709040
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Validation activities in Japan: a report.
    Ono H
    Altern Lab Anim; 2004 Jun; 32 Suppl 1B():631-4. PubMed ID: 23581151
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Collaboration between ZEBET, FRAME, and ECVAM: FRAME's contribution to establishing the Three Rs in Europe.
    Spielmann H
    Altern Lab Anim; 2009 Dec; 37 Suppl 2():23-7. PubMed ID: 20105007
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The fish embryo toxicity test as an animal alternative method in hazard and risk assessment and scientific research.
    Embry MR; Belanger SE; Braunbeck TA; Galay-Burgos M; Halder M; Hinton DE; Léonard MA; Lillicrap A; Norberg-King T; Whale G
    Aquat Toxicol; 2010 Apr; 97(2):79-87. PubMed ID: 20061034
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Skin sensitisation--moving forward with non-animal testing strategies for regulatory purposes in the EU.
    Basketter D; Alépée N; Casati S; Crozier J; Eigler D; Griem P; Hubesch B; de Knecht J; Landsiedel R; Louekari K; Manou I; Maxwell G; Mehling A; Netzeva T; Petry T; Rossi LH
    Regul Toxicol Pharmacol; 2013 Dec; 67(3):531-5. PubMed ID: 24140884
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Animal models in biological and biomedical research - experimental and ethical concerns.
    Andersen ML; Winter LMF
    An Acad Bras Cienc; 2019; 91(suppl 1):e20170238. PubMed ID: 28876358
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The ECVAM international validation study on in vitro embryotoxicity tests: results of the definitive phase and evaluation of prediction models. European Centre for the Validation of Alternative Methods.
    Genschow E; Spielmann H; Scholz G; Seiler A; Brown N; Piersma A; Brady M; Clemann N; Huuskonen H; Paillard F; Bremer S; Becker K
    Altern Lab Anim; 2002; 30(2):151-76. PubMed ID: 11971753
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The principles of validation and the ECVAM validation process.
    Worth AP; Balls M
    Altern Lab Anim; 2002 Dec; 30 Suppl 2():15-21. PubMed ID: 12513647
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Scientific and Regulatory Policy Committee Review: Review of the Organisation for Economic Co-operation and Development (OECD) Guidance on the GLP Requirements for Peer Review of Histopathology.
    Fikes JD; Patrick DJ; Francke S; Frazier KS; Reindel JF; Romeike A; Spaet RH; Tomlinson L; Schafer KA;
    Toxicol Pathol; 2015 Oct; 43(7):907-14. PubMed ID: 26208968
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The role of ECVAM in promoting the regulatory acceptance of alternative methods in the European Union. European Centre for the Validation of Alternative Methods.
    Worth AP; Balls M
    Altern Lab Anim; 2001; 29(5):525-35. PubMed ID: 11604096
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A Brazilian in the Reich of Wilhelm II: Henrique da Rocha Lima, Brazil-Germany relations and the Instituto Oswaldo Cruz, 1901-1909.
    Silva AF
    Hist Cienc Saude Manguinhos; 2013 Mar; 20(1):93-117. PubMed ID: 23559048
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fighting trafficking of falsified and substandard medicinal products in Russia.
    Fayzrakhmanov NF
    Int J Risk Saf Med; 2015; 27 Suppl 1():S37-40. PubMed ID: 26639702
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.